As of April 19, 2025, AC Immune (ACIU) has a market cap of $0.15 billion USD. According to our data, AC Immune is ranked No.7264 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.15 B |
-44.37%
|
Dec 31, 2024 | $0.27 B |
-46.00%
|
Dec 29, 2023 | $0.49 B |
145.10%
|
Dec 30, 2022 | $0.20 B |
-58.79%
|
Dec 31, 2021 | $0.49 B |
-4.26%
|
Dec 31, 2020 | $0.51 B |
-39.32%
|
Dec 31, 2019 | $0.84 B |
-9.84%
|
Dec 31, 2018 | $0.94 B |
-26.17%
|
Dec 29, 2017 | $1.27 B |
-1.39%
|
Dec 30, 2016 | $1.28 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Takeda Pharmaceutical
TAK
|
$46.30 B |
0.000 M
|
![]() Japan
|
Market Cap | = | ACIU Stock Price | * | ACIU Shares Outstanding |
= | $1.48 | * | 0.10 B | |
= | $0.15 B |